The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model

Vaccine

Volumn 16, Issue 4, 1998, Pages 410-416

  Willems, Rob J L ^a,b   Kamerbeek, Judith ^b   Geuijen, Cecile A W ^b   Top, Janetta ^b   Gielen, Henk ^b   Gaastra, Wim ^c   Mooi, Frits R ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

B parapertussis; Protection; Whole cell pertussis vaccine

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MANUFACTURE; FEMALE; FIMBRIA; IMMUNIZATION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032008117     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)80919-X     Document Type: Article

References (34)

1. 1 Miller, E. and Farrington, C.P. The current epidemiology of pertussis in the developed world: UK and West Germany. Tokai J. Exp. Med. 1988, 13, (Suppl.), 97-101.
2. 2 Willems, R.J.L. and Mooi, F.R. From whole cell to acellular pertussis vaccines. Rev. Med. Microbiol. 1996, 7, 13-21.
3. 3 Trollfors, B., Taranger, J. and Lagergard, T. et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 1995, 333, 1045-1050.
4. 4 Wirsing von König, C.H. and Finger, H. Efficacy of acellular pertussis vaccines. Immun. Infekt. 1995, 23, 125-129.
5. 5 Linnemann, C.C. and Perry, E.B. Bordetella parapertussis. Recent experience and a review of the literature. Am. J. Dis. Child. 1977, 131, 560-563.
6. 6 Zee van der, A., Agterberg, C., Peeters, M., Mooi, F. and Schellekens, J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J. Infect. Dis. 1996, 174, 89-96.
7. 7 Borska, K. and Simkovicova, M. Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J. Hyg. Epidemiol. Microbiol. Immunol. 1972, 16, 159-172.
8. 8 Celko, A., Burianova, B., Maixnerova, M., Stribrny, J., Zikmundova, V. and Zikmund, V. Transplacental antibodies. Part I: Maternal antibodies against B. pertussis and O. parapertussis. J. Hyg. Epidemiol. Microbiol. Immunol. 1984, 28, 465-469.
9. 9 Flosdorf, E.W., Bondi, A., Felton, H. and McGuinness, A.C. Studies with Hemophilus pertussis: comparative antgenic analysis of Bacillus parapertussis and Hemophilus pertussis, phase I, with consideration of clinical significance. J. Pediatr. 1942, 21, 625-634.
10. 10 Heininger, U., Stehr, K. and Schmitt-Grohe, S. et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness causd by Bordetella pertussis. Pediatr. Infect. Dis. J. 1994, 13, 306-309.
11. 11 Neimark, P.M., Lugovaya, L.V. and Belova, N.D. Bordetella parapertussis and its significance in the disease of pertussis. J. Microbiol. Epidemiol. Immunobiol. 1961, 32, 49-53.
12. 12 Wirsing von König, C.H. and Finger, H. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13, 455-458.
13. 13 Khelef, N., Danve, B., Quentin-Millet, M.J. and Guiso, N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immunol. 1993, 61, 486-490.
14. 14 Arico, B. and Rappuoli, R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J. Bacteriol. 1987, 169, 2847-2853.
15. 15 Marchitto, K.S., Smith, S.G., Locht, C. and Keith, J.M. Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect. Immunol. 1987, 55, 497-501.
16. 16 Taranger, J., Trollfors, B., Lagergard, T. and Zackrisson, G. Parapertussis infection followed by pertussis infection. Lancet 1994, 344, 1703
17. 17 Lautrop, H. Epidemics of parapertussis. 20 years' observations in Denmark. Lancet 1971, 1, 1195-1198.
18. 18 Relman, D.A., Domenighini, M., Tuomanen, E., Rappuoli, R. and Falkow, S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc. Natl Acad. Sci. U.S.A. 1989, 86, 2637-2641.
19. 19 Mooi, F.R., van der Heide, H.G. and ter Avest, A.R. et al. Characterization of fimbrial subunits from Bordetella species. Microbiol. Pathogen. 1987, 2, 473-484.
20. 20 Verwey, W.F., Thiele, E.H., Sage, D.N. and Schuckhardt, L.T. A simplified liquid culture medium for the growth of Haemophilus pertussis. J. Bacteriol. 1949, 50, 127-134.
21. 21 van Hemert, P.A. Specific properties of acid precipitated pertussis vaccine. Pogr. Immunobiol. Stand. 1969, 3, 297-301.
22. 22 Robinson, A., Gorringe, A.R., Funnell, S.G. and Fernandez, M. Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 1989, 7, 321-324.
23. 23 Amano, K., Fukushi, K. and Watanabe, M. Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J. Gen. Microbiol. 1990, 136, 81-487.
24. 24 Archambault, D., Rondeau, P., Martin, D. and Brodeur, B.R. Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A. J. Gen. Microbiol. 1991, 137, 905-911.
25. 25 Li, J., Fairweather, N.F., Novotny, P., Dougan, G. and Charles, I.G. Cloning, nucleotide sequence and heterologous expression of the protective outer membrane protein P.68 pertactin from Bordetella bronchiseptica. J. Gen. Microbiol. 1992, 138, 1697-1705.
26. 26 Mooi, F.R. Bordetella pertussis fimbriae. In Fimbriae: Adhesion, Genetics, Biogenesis, and Vaccines (Ed. Klemm, P.). CRC Press, Boca Raton, FA, USA, 1994, pp. 115-126
27. 27 Guiso, N., Rocancourt, M., Szatanik, M. and Alonso, J.M. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Microbiol. Pathog. 1989, 7, 373-380.
28. 28 Guiso, N., Szatanik, M. and Rocancourt, M. Protective activity of Bordetella adenylate cyclase hemolysin against bacterial colonization. Microbiol. Pathog. 1991, 11, 423-431.
29. 29 Walker, R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994, 12, 387-400.
30. 30 Robbins, J.B., Schneerson, R. and Szu, S.C. Hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 1995, 171, 1387-1398.
31. 31 Ashworth, L.A., Fitzgeorge, R.B., Irons, L.I., Morgan, C.P. and Robinson, A. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J. Hyg. London 1982, 88, 475-486.
32. 32 Edwards, K.M., Meade, B.D. and Decker, M.D. et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995, 96, 548-556.
33. 33 Pearce, A.M., Seabrook, R.N., Irons, L.I., Ashworth, L.A.E., Atkinson, T. and Robinson, A. Localization of antigenic domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae. Microbiology 1994, 140, 205-211.
34. 34 Williamson, P. and Matthews, R. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol. Med. Microbiol. 1996, 13, 169-178.